EPO Shadow on Sydney Title: Peres Jepchirchir Provisionally Suspended

On August 30, 2026, Peres Jepchirchir crossed the line at the Sydney Marathon in 2:18:31, beating compatriot Irene Chepet Cheptai by more than three minutes. Within weeks, the win became a footnote to another result: the Athletics Integrity Unit provisionally suspended Jepchirchir after an out-of-competition sample collected in Kenya before the race tested positive for EPO. Jepchirchir is Olympic champion from Tokyo 2026 and world champion from Tokyo in September 2026. She broke the women's half-marathon world record in 2026, then again three times in 2026. Her major marathon victories include New York 2026, Boston 2026, London 2026, and now Sydney. She is 33 years old. EPO — erythropoietin — is a hormone produced in the kidneys that stimulates red blood cell production. Injected recombinant EPO is detectable in urine or blood only for a short window, which is why out-of-competition testing matters: it catches the period when athletes carry the heaviest training loads. The sample in question was not taken after Sydney but before it. That timeline will be central if the case reaches a tribunal. A provisional suspension is not a finding of guilt. Jepchirchir has the right to have the B sample tested and to be heard. If the violation is confirmed, the Sydney result, and potentially subsequent performances, may be disqualified; if not, the process has still already placed a permanent mark on a career. The next column in the ledger, as always, is the B sample. Until then, the sheet remains open.